Home » Topics » Regulatory

Regulatory
RSS

FDA approves Xgeva to treat giant cell tumor of bone

June 14, 2013

No Comments

FDA approves Fluzone Quadrivalent influenza vaccine

June 10, 2013

No Comments

FDA approves lenalidomide for relapsed/refractory mantle cell lymphoma

June 6, 2013

No Comments

FDA approves two new GSK drugs, companion diagnostic for unresectable or metastatic melanoma

May 30, 2013

No Comments

Bayer's Xarelto approved in Europe for additional indication

May 28, 2013

No Comments

Netherlands first to approve Vesomni

May 23, 2013

No Comments

Baxter obtains marketing approval in Europe for HyQvia

May 22, 2013

No Comments

FDA approves Xofigo in treatment of CRPC with bone metastases

May 16, 2013

No Comments

Janssen obtains FDA approval for use of Simponi in new indication

May 16, 2013

No Comments

FDA approves Breo Ellipta for treatment of COPD

May 13, 2013

No Comments

BioWorld Premium

Enjoy extended coverage for the most complete market view with BioWorld, BioWorld MedTech, and BioWorld Asia in a single, easy to access subscription.

Regulatory
RSS

FDA approves Xgeva to treat giant cell tumor of bone

FDA approves Fluzone Quadrivalent influenza vaccine

FDA approves lenalidomide for relapsed/refractory mantle cell lymphoma

FDA approves two new GSK drugs, companion diagnostic for unresectable or metastatic melanoma

Bayer's Xarelto approved in Europe for additional indication

Netherlands first to approve Vesomni

Baxter obtains marketing approval in Europe for HyQvia

FDA approves Xofigo in treatment of CRPC with bone metastases

Janssen obtains FDA approval for use of Simponi in new indication

FDA approves Breo Ellipta for treatment of COPD

Today's news in brief

Today's news in brief

Enhanced Cognition: Lewy body dementia phase II pumps stock

Experimental mRNA gene therapy suppresses preeclampsia in mice

Drug duo to Repare lack in gyno cancers? Phase I shows promise

Regulatory RSS

Regulatory
RSS